Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $9.97M | ﹤0.01% |
248,826
+177,837
| +251% | +$6.67M |
|
|
OPLN
2527
Openlane
OPLN
$4.33B
| $9.96M | ﹤0.01% |
535,288
-835,293
| -61% | -$14.4M |
|
2528
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $9.96M | ﹤0.01% |
78,100
+8,300
| +12% | +$987K |
|
2529
Xos
XOS
$29.9M
| $9.92M | ﹤0.01% |
+32,851
| New | +$9.86M |
|
2530
State Street Utilities Select Sector SPDR ETF
XLU
$23B
| $9.91M | ﹤0.01% |
316,020
-7,420
| -2% | -$235K |
|
2531
CALL
CryoPort
CYRX
$772M
| $9.9M | ﹤0.01% |
225,600
-25,400
| -10% | -$1.21M |
|
2532
PUT
PVH
PVH
$3.8B
| $9.88M | ﹤0.01% |
105,200
-7,000
| -6% | -$533K |
|
2533
CALL
Repligen
RGEN
$9.42B
| $9.87M | ﹤0.01% |
51,500
+28,400
| +123% | +$5.17M |
|
2534
Cameco
CCJ
$42.6B
| $9.87M | ﹤0.01% |
736,422
-321,057
| -30% | -$3.43M |
|
|
BCEL
2535
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $9.86M | ﹤0.01% |
610,545
+33,480
| +6% | +$502K |
|
2536
CALL
Children's Place
PLCE
$54.3M
| $9.86M | ﹤0.01% |
196,700
-6,300
| -3% | -$229K |
|
2537
Sensata Technologies
ST
$6.73B
| $9.84M | ﹤0.01% |
186,583
-173,052
| -48% | -$8.32M |
|
2538
CALL
J.M. Smucker
SJM
$13B
| $9.84M | ﹤0.01% |
85,100
-35,600
| -29% | -$4.14M |
|
|
LNW
2539
CALL
DELISTED
Light & Wonder
LNW
| $9.82M | ﹤0.01% |
236,600
-111,500
| -32% | -$4.11M |
|
2540
PUT
Rapid7
RPD
$876M
| $9.81M | ﹤0.01% |
108,800
+81,700
| +301% | +$5.84M |
|
2541
iShares Mortgage Real Estate ETF
REM
$546M
| $9.8M | ﹤0.01% |
307,680
+91,937
| +43% | +$2.66M |
|
2542
CALL
Welltower
WELL
$170B
| $9.8M | ﹤0.01% |
151,600
-135,100
| -47% | -$8.2M |
|
2543
PUT
Riot Platforms
RIOT
$7.14B
| $9.78M | ﹤0.01% |
575,700
+334,900
| +139% | +$2.23M |
|
2544
PUT
Enterprise Products Partners
EPD
$84B
| $9.78M | ﹤0.01% |
499,200
-443,500
| -47% | -$8.26M |
|
2545
American Express Global Business Travel
GBTG
$4.94B
| $9.78M | ﹤0.01% |
+939,086
| New | +$9.53M |
|
2546
Ligand Pharmaceuticals
LGND
$5.87B
| $9.75M | ﹤0.01% |
157,112
-206,028
| -57% | -$11.7M |
|
2547
PUT
Prologis
PLD
$134B
| $9.75M | ﹤0.01% |
97,800
+6,000
| +7% | +$607K |
|
2548
Genmab
GMAB
$19.6B
| $9.72M | ﹤0.01% |
239,132
-43,578
| -15% | -$1.63M |
|
2549
WD-40
WDFC
$3.08B
| $9.72M | ﹤0.01% |
36,577
+3,044
| +9% | +$737K |
|
2550
PUT
Lumentum
LITE
$82.1B
| $9.7M | ﹤0.01% |
102,300
-86,800
| -46% | -$7.49M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.